Engene Holdings Inc (ENGN)

Feb 27, 2025

Lumira Ventures Portfolio Company enGene (Nasdaq:ENGN) Debuts as Publicly Traded Genetic Medicines Company - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

enGene Holdings Inc.: Unknown Company Which Looks Like A Catch (NASDAQ:ENGN) - Seeking Alpha

Feb 27, 2025

Feb 25, 2025

Financial Contrast: enGene (NASDAQ:ENGN) versus iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Feb 25, 2025

Feb 22, 2025

(ENGN) On The My Stocks Page - Stock Traders Daily

Feb 22, 2025

Feb 22, 2025

Vontobel Holding Ltd. Makes New $69,000 Investment in enGene Holdings Inc. (NASDAQ:ENGN) - Defense World

Feb 22, 2025

Feb 22, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Feb 22, 2025

Feb 19, 2025

enGene Holdings GAAP EPS of -$0.38 - MSN

Feb 19, 2025

Feb 19, 2025

New Strong Buy Stocks for February 19th - Zacks Investment Research

Feb 19, 2025

Feb 19, 2025

enGene (NASDAQ:ENGN) Now Covered by Piper Sandler - Defense World

Feb 19, 2025

Feb 19, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Given Average Rating of “Buy” by Brokerages - Defense World

Feb 19, 2025

Feb 18, 2025

Piper Sandler sets $26 target on Engene shares with Overweight rating - Investing.com Australia

Feb 18, 2025

Feb 18, 2025

This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Feb 18, 2025

Feb 18, 2025

Buy Rating for enGene Holdings: Strategic Positioning and Growth Potential in NMIBC Market - TipRanks

Feb 18, 2025

Feb 18, 2025

Piper Sandler Initiates Coverage on enGene Holdings With Overweight Rating, $26 Price Target - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

Piper Sandler sets $26 target on Engene shares with Overweight rating By Investing.com - Investing.com South Africa

Feb 18, 2025

Feb 17, 2025

Analyzing Ratios: enGene Holdings Inc (ENGN)’s Financial Story Unveiled - The Dwinnex

Feb 17, 2025

Feb 16, 2025

enGene (NASDAQ:ENGN) Stock Rating Lowered by UBS Group - Defense World

Feb 16, 2025

Feb 15, 2025

enGene (NASDAQ:ENGN) Downgraded to Neutral Rating by UBS Group - MarketBeat

Feb 15, 2025

Feb 14, 2025

Sector Update: Health Care -February 14, 2025 at 03:41 pm EST - Marketscreener.com

Feb 14, 2025

Feb 14, 2025

EnGene Holdings Shares Fall After UBS Downgrade -February 14, 2025 at 02:55 pm EST - Marketscreener.com

Feb 14, 2025

Feb 14, 2025

UBS Downgrades enGene Holdings to Neutral From Buy, Cuts Price Target to $7 From $34 - Marketscreener.com

Feb 14, 2025

Feb 14, 2025

enGene downgraded to Neutral from Buy at UBS - TipRanks

Feb 14, 2025

Feb 11, 2025

(ENGN) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Feb 11, 2025

Feb 07, 2025

enGene Holdings Inc (ENGN) vs. Its Peers: A Comparison - The News Heater

Feb 07, 2025

Feb 04, 2025

enGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire

Feb 04, 2025

Jan 31, 2025

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Jan 31, 2025

Jan 31, 2025

Where are the Opportunities in (ENGN) - Stock Traders Daily

Jan 31, 2025

Jan 31, 2025

Cancer Biotech enGene Strengthens Team with $1.9M Equity Package as Bladder Cancer Trial Advances - StockTitan

Jan 31, 2025

Jan 30, 2025

ENGNenGene Holdings Inc. Latest Stock News & Market Updates - StockTitan

Jan 30, 2025

Jan 30, 2025

enGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) - Business Wire

Jan 30, 2025

Jan 26, 2025

FY2026 EPS Estimates for enGene Boosted by Leerink Partnrs - Defense World

Jan 26, 2025

Jan 25, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Jan 25, 2025

Jan 25, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Receives Average Rating of “Buy” from Analysts - Defense World

Jan 25, 2025

Jan 24, 2025

Leerink Partnrs Brokers Lift Earnings Estimates for enGene - MarketBeat

Jan 24, 2025

Jan 23, 2025

FY2029 EPS Estimates for enGene Reduced by Leerink Partnrs - MarketBeat

Jan 23, 2025

Jan 23, 2025

enGene Announces Oversubscribed $200 Million Private Placement F - GuruFocus.com

Jan 23, 2025

Jan 20, 2025

(ENGN) Proactive Strategies - Stock Traders Daily

Jan 20, 2025

Jan 20, 2025

Insider Returns Down To US$14k As enGene Holdings' Stock Dips 11% - Simply Wall St

Jan 20, 2025

Jan 11, 2025

How Much Upside is Left in enGene Holdings Inc. (ENGN)? Wall Street Analysts Think 238.77% - MSN

Jan 11, 2025

Jan 10, 2025

(ENGN) Trading Report - Stock Traders Daily

Jan 10, 2025

Jan 04, 2025

enGene Holdings Inc. (ENGN) Upgraded to Strong Buy: Here's Why - MSN

Jan 04, 2025

Dec 31, 2024

enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Dec 31, 2024

Dec 31, 2024

enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Rating of “Buy” by Analysts - Defense World

Dec 31, 2024

Dec 30, 2024

(ENGN) Technical Pivots with Risk Controls - Stock Traders Daily

Dec 30, 2024

Dec 30, 2024

enGene Holdings Awards Stock Options to New Employees in Key Talent Acquisition Move | ENGN Stock News - StockTitan

Dec 30, 2024

Dec 28, 2024

enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Down 93.4% in December - MarketBeat

Dec 28, 2024

Dec 26, 2024

Engene Holdings Faces Regulatory Challenges and Business Risks Amid Clinical Trial Hurdles - MSN

Dec 26, 2024

Dec 26, 2024

HC Wainwright Forecasts enGene’s Q1 Earnings (NASDAQ:ENGN) - Defense World

Dec 26, 2024

Dec 25, 2024

What is HC Wainwright's Estimate for enGene Q1 Earnings? - MarketBeat

Dec 25, 2024

Dec 24, 2024

Engene shares initiated at Buy as promising detalimogene data positions it ahead of recent approvals - Investing.com Nigeria

Dec 24, 2024

Dec 24, 2024

enGene (NASDAQ:ENGN) Receives “Market Outperform” Rating from JMP Securities - Defense World

Dec 24, 2024

Dec 24, 2024

enGene (NASDAQ:ENGN) Now Covered by Analysts at HC Wainwright - Defense World

Dec 24, 2024